Search Results

25 search results found

Cracking Cancer 2.0 - Lightning Talks

December 7, 2017 | Startup Exchange Video | Duration: 30:6

Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
Past Deadline: Feb 25, 2020

Anglo American seeking startups for February visit

meeting

Anglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.
Decoy Therapeutics Inc.

Cambridge, MA

Biotechnology

The 21st century is experiencing epidemics and pandemics with increasing frequency, and the world needs new tools to combat these diseases. Decoy's platform engineers new pan-viral drugs that address both existing and new zoonotic viral threats. Our lead antiviral nasal spray has demonstrated... More

Keywords:

peptide conjugate, Antiviral, PPMO, PNA, fusion peptide, pan-viral family, SARS-CoV-2, RSV, self-administered drug
Immunai

New York, NY

Immunai is an end-to-end computational immunology company leveraging the power of single-cell biology and AI to decode the Immune System to improve health and accelerate therapeutics.

Keywords:

single-cell sequencing, single-cell genomics, machine learning, Artificial Intelligence
PathAI

Boston, MA

Biotechnology

The mission at PathAI is to transform, accelerate and improve cancer diagnosis and cancer care by integrating pathology machine learning / artificial intelligence (AI) with traditional pathology methods in both research and clinical labs. By leveraging recent advances in computational processing... More
Volta Labs, Inc.

Cambridge, MA

Biotechnology

Volta Labs, Inc. makes programmable fluidic chips for biological automation. We are a transdisciplinary team combining electronics manufacturing, material science, biochemistry and computer science to enable next-generation of automation for genetic engineering. The vision is to bring the... More
BioBuilder

April 25, 2016 | Startup Exchange Video | Duration: 15:21

Natalie Kuldell, President, Founder, & Executive Director, BioBuilder Educational Foundation
Tue, July 16, 2024 | Conference

2024 MIT Tokyo Life Science Symposium - Startup Exchange Lightning Talks

Tokyo, Japan

Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.
Kytopen Corporation

Cambridge, MA

Biotechnology

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More

Keywords:

Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
Cellino Biotech, Inc.

Cambridge, MA

Biotechnology

Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More

Search Results

Filter Results